Literature DB >> 15218806

The pathology of primary progressive multiple sclerosis.

Claudia Lucchinetti1, Wolfgang Bruck.   

Abstract

The pathological hallmark of chronic multiple sclerosis includes focal demyelination, gliosis, inflammation and axonal injury. There is limited information on whether these pathological features differ across the clinical phenotypes of the disease (relapsing-remitting, secondary progressive, and primary progressive). This review will focus on the pathological aspects of PPMS and pathogenic implications. A better understanding of the differences in PPMS pathology and pathogenesis will lead to more effective treatment strategies.

Entities:  

Mesh:

Year:  2004        PMID: 15218806     DOI: 10.1191/1352458504ms1027oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  11 in total

1.  Comprehensive immunophenotyping of cerebrospinal fluid cells in patients with neuroimmunological diseases.

Authors:  Sungpil Han; Yen Chih Lin; Tianxia Wu; Alan D Salgado; Ina Mexhitaj; Simone C Wuest; Elena Romm; Joan Ohayon; Raphaela Goldbach-Mansky; Adeline Vanderver; Adriana Marques; Camilo Toro; Peter Williamson; Irene Cortese; Bibiana Bielekova
Journal:  J Immunol       Date:  2014-02-07       Impact factor: 5.422

2.  Platelet-derived growth factor promotes repair of chronically demyelinated white matter.

Authors:  Adam C Vana; Nicole C Flint; Norah E Harwood; Tuan Q Le; Marcus Fruttiger; Regina C Armstrong
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

3.  Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.

Authors:  Jonathan P C Hasselmann; Hawra Karim; Anna J Khalaj; Subir Ghosh; Seema K Tiwari-Woodruff
Journal:  J Neurosci Methods       Date:  2017-04-08       Impact factor: 2.390

Review 4.  Myelin repair: the role of stem and precursor cells in multiple sclerosis.

Authors:  Siddharthan Chandran; David Hunt; Alexis Joannides; Chao Zhao; Alastair Compston; Robin J M Franklin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2008-01-12       Impact factor: 6.237

Review 5.  Axonal Degeneration during Aging and Its Functional Role in Neurodegenerative Disorders.

Authors:  Natalia Salvadores; Mario Sanhueza; Patricio Manque; Felipe A Court
Journal:  Front Neurosci       Date:  2017-09-04       Impact factor: 4.677

6.  Personalized pathology maps to quantify diffuse and focal brain damage.

Authors:  G Bonnier; E Fischi-Gomez; A Roche; T Hilbert; T Kober; G Krueger; C Granziera
Journal:  Neuroimage Clin       Date:  2018-11-20       Impact factor: 4.881

Review 7.  Remyelination-promoting human IgMs: developing a therapeutic reagent for demyelinating disease.

Authors:  A E Warrington; M Rodriguez
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

8.  Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis.

Authors:  Z Khaleeli; J Sastre-Garriga; O Ciccarelli; D H Miller; A J Thompson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-07       Impact factor: 10.154

Review 9.  Experimental and therapeutic opportunities for stem cells in multiple sclerosis.

Authors:  Rickie Patani; Siddharthan Chandran
Journal:  Int J Mol Sci       Date:  2012-11-08       Impact factor: 5.923

10.  Brain and spinal cord MRI lesions in primary progressive vs. relapsing-remitting multiple sclerosis.

Authors:  Akram Dastagir; Brian C Healy; Alicia S Chua; Tanuja Chitnis; Howard L Weiner; Rohit Bakshi; Shahamat Tauhid
Journal:  eNeurologicalSci       Date:  2018-07-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.